Peripheral Neuropathy

Overview

Journal Med Clin North Am

Specialty General Medicine

Date 2019 Feb 2

PMID 30704689

Citations 56

Authors

Kelsey Barrell

A Gordon Smith

Affiliations

Soon will be listed here.

Abstract

Peripheral neuropathy is a commonly encountered disorder in clinical practice. In light of an aging population and the diabetes and obesity pandemic, the prevalence of peripheral neuropathy is increasing, posing a significant public health concern. This article provides a diagnostic framework for neuropathies and summarizes treatment options.

Citing Articles

Which fluoroquinolone is safer when combined with bedaquiline for tuberculosis treatment: evidence from FDA Adverse Event Reporting System database from 2013 to 2024.

Wei S, He C, Xie X, Zhang A, Tang S, Li S Front Pharmacol. 2024; 15:1491921.

PMID: 39726777 PMC: 11669847. DOI: 10.3389/fphar.2024.1491921.

The neuroprotective effects of progesterone against peripheral neuropathy: a systematic review of non-clinical studies.

Haghi-Aminjan H, Kouhestani M, Hosseini A Metab Brain Dis. 2024; 40(1):9.

PMID: 39556122 DOI: 10.1007/s11011-024-01480-y.

Evaluation of Effectiveness and Safety of Firstline Drugs Used in the Treatment of Peripheral Neuropathy Among Elderly Population-A Randomised, Open-label, Active Comparator Study.

Balasundaram M, Kannauje P, Dhaneria S, Singh A Ann Neurosci. 2024; :09727531241243126.

PMID: 39544662 PMC: 11559800. DOI: 10.1177/09727531241243126.

3D color-rendered MR neurography heatmaps in visualizing normal lumbosacral (LS) plexus and increasing conspicuity of LS plexopathy.

He A, Ray G, Pezeshk P, Eajazi A, Karatas R, Rayer D Eur Radiol. 2024; 35(3):1679-1686.

PMID: 39453474 DOI: 10.1007/s00330-024-11138-z.

Knowledge levels of oncology nurses regarding evidence-based practices in the assessment and management of chemotherapy-induced peripheral neuropathy.

Celik A, Usta Yesilbalkan O Asia Pac J Oncol Nurs. 2024; 11(10):100581.

PMID: 39310727 PMC: 11416514. DOI: 10.1016/j.apjon.2024.100581.